Skip to main content
Log in

Hypnotics in the Elderly

What Cause for Concern?

  • Review Article
  • Published:
Drugs Aims and scope Submit manuscript

Summary

At any age hypnotic drug use can give rise to 3 major problems: unwanted effects on daytime mood and behaviour associated with drug consumption; rebound effects associated with drug withdrawal; and dependency associated with long term drug use. For 2 reasons elderly hypnotic users are both more vulnerable and more exposed to each of these problems. Firstly, age-related changes in pharmacodynamic and pharmacokinetic processes amplify the behavioural impact of many hypnotics; and secondly, age-related changes in the structure and quality of sleep tend to increase the demand for, and the long term use of, sedative hypnotic compounds in old age. The existence of physical illness, cognitive impairment, or daytime behaviour already compromised by normal aging processes further increases the likelihood of hypnotic drugs detrimentally affecting well-being in later life.

These important causes for concern emphasise the need for 2 separate clinical responses: the need for greater circumspection in the choice and use of hypnotic drugs among elderly patients, and the need for a more broadly based clinical approach to the management of sleep problems in old age.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Adam K, Adamson L, Brezinova V, Hunter WM, Oswald I. Nitrazepam: lastingly effective but trouble on withdrawal. British Medical Journal 1: 1558–1560, 1976

    Article  PubMed  CAS  Google Scholar 

  • Adam K, Oswald I. Can a rapidly eliminated hypnotic cause daytime anxiety? Pharmacopsychiatry 22: 115–119, 1989

    Article  PubMed  CAS  Google Scholar 

  • Adam K, Oswald I, Shapiro C. Effects of loprazolam and triazolam on sleep and overnight urinary cortisol. Psychopharmacology 82: 389–394, 1984

    Article  PubMed  CAS  Google Scholar 

  • Ancoli-Israel S, Kripke DF, Mason W, Kaplan OJ. Sleep apnea and periodic movements in an aging sample. Journal of Gerontology 40: 419–425, 1985

    PubMed  CAS  Google Scholar 

  • Ashton H. Benzodiazepine withdrawal: an unfinished story. British Medical Journal 288: 1135–1140, 1984

    Article  PubMed  CAS  Google Scholar 

  • Bliwise DL, Feldman DE, Bliwise NG, Carskadon MA, Kraemer HC, et al. Risk factors for sleep disordered breathing in heterogeneous geriatric populations. Journal of the American Geriatrics Society 35: 132–141, 1987

    PubMed  CAS  Google Scholar 

  • Briggs RS, Castleden CM, Kraft CA. Improved hypnotic treatment using chlormethiazole and temazepam. British Medical Journal 1: 601–604, 1980

    Article  Google Scholar 

  • Buck JA. Psychotropic drug practice in nursing homes. Journal of the American Geriatrics Society 36: 409–418, 1988

    PubMed  CAS  Google Scholar 

  • Castleden CM, George CF, Marcer D, Hallett C. Increased sensitivity to nitrazepam in old age. British Medical Journal 1: 10–12, 1977

    Article  PubMed  CAS  Google Scholar 

  • Clark TJH, Collins JV, Tong D. Respiratory depression caused nitrazepam in patients with respiratory failure. Lancet 2: 737–738, 1971

    Article  PubMed  CAS  Google Scholar 

  • Coleman RM, Miles LE, Guilleminault CC, Zarcone VP, van den Hoed J, et al. Sleep-wake disorders in the elderly: a polysomnographic analysis. Journal of the American Geriatrics Society 29: 289–296, 1981

    PubMed  CAS  Google Scholar 

  • Committee on the Review of Medicines. Systematic review of the benzodiazepines. British Medical Journal 1: 910–912, 1980

    Google Scholar 

  • Cook PJ. Benzodiazepines in the elderly. Acta Psychiatrica Scandinavica 74 (Suppl. 332): 149–158, 1986

    Article  Google Scholar 

  • Cook PJ, Huggett A, Graham-Pole R, Savage IT, James IA. Hypnotic accumulation and hangover in elderly inpatients: a controlled double-blind study of temazepam and nitrazepam. British Medical Journal 286: 100–102, 1983

    Article  PubMed  CAS  Google Scholar 

  • Department of Health. Health and personal social service statistics for England, HMSO, London, 1989

  • Dolly FR, Block AJ. Effect of flurazepam on sleep-disordered breathing and nocturnal oxygen desaturation in asymptomatic subjects. American Journal of Medicine 73: 239–243, 1982

    Article  PubMed  CAS  Google Scholar 

  • Dunbar GC, Perera MH, Jenner FA. Patterns of benzodiazepine use in Great Britain as measured by a general population survey. British Journal of Psychiatry 155: 836–841, 1989

    Article  PubMed  CAS  Google Scholar 

  • Dunnell K, Cartwright A. Medicine takers, prescribers and hoarders, Routledge and Keegan, London, 1972

  • Evans JG, Jarvis EH. Nitrazepam and the elderly. British Medical Journal 4: 487, 1972

    Article  PubMed  CAS  Google Scholar 

  • Fruensgaard K. Withdrawal psychosis: a study of 30 consecutive cases. Acta Psychiatrica Scandinavica 53: 105–118, 1976

    Article  PubMed  CAS  Google Scholar 

  • Gaillot J, Heusse D, Houghton G, Aurele J-M, Dreyfus J. Pharmacokinetics and metabolism of zopiclone. Pharmacology 27 (Suppl. 2): 76–91, 1983

    Article  PubMed  CAS  Google Scholar 

  • Goa KL, Heel RC. Zopiclone: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy as a hypnotic. Drugs 32: 48–65, 1986

    Article  PubMed  CAS  Google Scholar 

  • Greenblatt DJ, Allen MD. Toxicity of nitrazepam in the elderly: a report from the Boston Collaborative Drug Surveillance Program. British Journal of Clinical Pharmacology 5: 407–413, 1978

    Article  PubMed  CAS  Google Scholar 

  • Greenblatt DJ, Allen MD, Shader RI. Toxicity of high-dose flurazepam in the elderly. Clinical Pharmacology and Therapeutics 21: 355–361, 1977

    PubMed  CAS  Google Scholar 

  • Hicks R, Dysken MW, Davis JM, Lesser J, Ripeckyj A, et al. The pharmacokinetics of psychotropic drugs in the elderly: a review. Journal of Clinical Psychiatry 42: 374–385, 1981

    PubMed  CAS  Google Scholar 

  • Houghton G, Dennis M, Templeton R, Martin B. A repeated dose pharmacokinetic study of a new hypnotic agent, zopiclone (Imovane®). International Journal of Clinical Pharmacology, Therapy and Toxicology 23: 97–100, 1985

    CAS  Google Scholar 

  • Ingman SR, Lawson IR, Pierpaoli PG, Blake P. A survey of the prescribing and administration of drugs in a long-term care institution for the elderly. Journal of the American Geriatrics Society 7: 309–316, 1975

    Google Scholar 

  • Kales A, Bixler EO, Soldatos CR, Vela-Bueno A, Jacoby J, et al. Quazepam and flurazepam: long-term use and extended withdrawal. Clinical Pharmacology and Therapeutics 32: 781–788, 1982

    Article  PubMed  CAS  Google Scholar 

  • Kales A, Soldatos CR, Bixler EO, Kales JD. Early morning insomnia with rapidly eliminated benzodiazepines. Science 220: 95–97, 1983

    Article  PubMed  CAS  Google Scholar 

  • Karacan I, Thornby JI, Anch M, Holzer CE, Warheit GJ, et al. Prevalence of sleep disturbance in a primarily urban Florida county. Social Science and Medicine 10: 239–244, 1976

    Article  CAS  Google Scholar 

  • Klimm HD, Dreyfus JF, Delmotte M. Zopiclone versus nitrazepam: a double-blind comparative study of efficacy and tolerance in elderly patients with chronic insomnia. Sleep 10 (Suppl.): 73–78, 1987

    PubMed  Google Scholar 

  • Kripke DF, Garfinkel L. Excess nocturnal deaths related to sleeping pill and tranquilliser use. Lancet 1: 99, 1984

    Article  PubMed  CAS  Google Scholar 

  • Kripke DF, Simons RN, Garfinkel L, Hammond EC. Short and long sleep and sleeping pills: is increased mortality associated? Archives of General Psychiatry 36: 103–116, 1979

    Article  PubMed  CAS  Google Scholar 

  • Lader M. The use and abuse of hypnotics. In Home & Page (Eds) Sleep disorders, pp. 1–8, Duphar Medical Relations, Southampton, 1989

    Google Scholar 

  • Lion JR, Azcarate C, Koepke HH. ‘Paradoxical rage reactions’ during psychotropic mediation. Diseases of the Nervous System 36: 557–558, 1975

    PubMed  CAS  Google Scholar 

  • Mellinger GD, Balter MB, Chase C, Manheimer DI. Patterns of psychotherapeutic drug use among adults in San Francisco. Archives of General Psychiatry 25: 385–397, 1971

    Article  PubMed  CAS  Google Scholar 

  • Model DG, Berry DJ. Effects of chlordiazepoxide in respiratory failure due to chronic bronchitis. Lancet 2: 869–870, 1974

    Article  PubMed  CAS  Google Scholar 

  • Morgan K. Effects of repeated dose nitrazepam and lormetazepam on psychomotor performance in the elderly. Psychopharmacology 86: 209–211, 1985

    Article  PubMed  CAS  Google Scholar 

  • Morgan K. Trends in hypnotic drug usage among elderly people. Abstract. Human Psychopharmacology Clinical and Experimental 5: 72–73, 1990

    Google Scholar 

  • Morgan K, Adam K, Oswald I. Effects of loprazolam and triazolam on psychological functions. Psychopharmacology 82: 386–388, 1984

    Article  PubMed  CAS  Google Scholar 

  • Morgan K, Dallosso H, Ebrahim S, Arie T, Fentem PH. Prevalence, frequency, and duration of hypnotic drug use among the elderly living at home. British Medical Journal 296, 601–602, 1988

    Article  PubMed  CAS  Google Scholar 

  • Morgan K, Gilleard CJ, Reive A. Hypnotic usage in residential homes for the elderly: a prevalence and longitudinal analysis. Age and Ageing 11: 229–234, 1982

    Article  PubMed  CAS  Google Scholar 

  • Morgan K, Oswald I. Anxiety caused by a short-life hypnotic. British Medical Journal 284: 942, 1982

    Article  PubMed  CAS  Google Scholar 

  • Morgan K, Tomeny M. Benzodiazepine withdrawal and rebound insomnia. Acta Psychiatrica Scandinavica 80: 297–298, 1989

    Article  PubMed  CAS  Google Scholar 

  • Murray J, Dunn G, Williams P, Tarnapolsky A. Factors affecting the consumption of psychotropic drugs. Psychological Medicine 11: 551–560, 1981

    Article  PubMed  CAS  Google Scholar 

  • Oswald I, Adam K, Borrow S, Idzikowski C. The effects of two hypnotics on sleep, subjective feelings and skilled performance. In Passouant & Oswald (Eds) Pharmacology of the states of alertness, pp. 51–63, Pergamon, Oxford, 1979

    Google Scholar 

  • Parker G, Roberts C. Plasma concentrations and central nervous system effects of the new hypnotic agent zopiclone in patients with chronic liver disease. British Journal of Clinical Pharmacology 16: 259–265, 1983

    Article  PubMed  CAS  Google Scholar 

  • Petursson H, Lader MH. Withdrawal from long-term benzodiazepine treatment. British Medical Journal 283: 643–645, 1984

    Article  Google Scholar 

  • Ray WR, Federspiel CF, Shaffner W. A study of antipsychotic drug use in nursing homes: epidemiologic evidence suggesting misuse. American Journal of Public Health 70: 485–491, 1980

    Article  PubMed  CAS  Google Scholar 

  • Ray WR, Griffin MR, Schaffner W, Baugh DK, Melton LJ. Psychotropic drug use and the risk of hip fracture. New England Journal of Medicine 316: 363–369, 1987

    Article  PubMed  CAS  Google Scholar 

  • Rigby J, Harvey M, Davies DR. Mania precipitated by benzodiazepine withdrawal. Acta Psychiatrica Scandinavica 79: 406–407, 1989

    Article  PubMed  CAS  Google Scholar 

  • Rodrigo EK, King MB, Williams P. Health of long term benzodiazepine users. British Medical Journal 296: 603–606, 1988

    Article  PubMed  CAS  Google Scholar 

  • Salzman C Kochansky GE, Shader RI, Porrino LJ, Harmatz JS, et al. Chlordiazepoxide-induced hostility in a small group setting. Archives of General Psychiatry 31: 401–405, 1974

    Article  PubMed  CAS  Google Scholar 

  • Salzman C, Van der Kolk B. Psychotropic drug prescriptions for elderly patients in a general hospital. Journal of the American Geriatrics Society 28: 18–22, 1980

    PubMed  CAS  Google Scholar 

  • Schneider-Helmert D. Why low-dose benzodiazepine-dependent insomniacs can’t escape their sleeping pills. Acta Psychiatrica Scandinavica 78: 706–711, 1989

    Article  Google Scholar 

  • Swift CG, Swift MR, Hamley J, Stevenson IH, Crooks J. Side-effect ‘tolerance’ in elderly long-term recipients of benzodiazepine hypnotics. Age and Ageing 13: 335–343, 1984

    Article  PubMed  CAS  Google Scholar 

  • Viukari M, Linnoila M, Halto U. Efficacy and side effects of flurazepam, and nitrazepam as sleeping aids in psychogeriatric patients. Acta Psychiatrica Scandinavica 57: 27–35, 1978

    Article  PubMed  CAS  Google Scholar 

  • Weedle PB, Poston JW, Parish PA. Use of hypnotic medicines by elderly people in residential homes. Journal of the Royal College of General Practitioners 38: 156–158, 1988

    PubMed  CAS  Google Scholar 

  • Williamson J, Chopin JM. Adverse reactions to prescribed drugs in the elderly: a multicentre investigation. Age and Ageing 9: 73–80, 1980

    Article  PubMed  CAS  Google Scholar 

  • Woods HW, Katz JL, Winger G. Abuse liability of benzodiazepines. Pharmacological Reviews 39: 251–413, 1987

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Morgan, K. Hypnotics in the Elderly. Drugs 40, 688–696 (1990). https://doi.org/10.2165/00003495-199040050-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199040050-00004

Keywords

Navigation